Details of the Drug

General Information of Drug (ID: DMCWT17)

• Drug Name: NV-1020

Indication

Disease Entry	ICD 11	Status	REF
Liver cancer	2C12	Phase 1/2	[1]

• Affected Organisms: Humans and other mammals
• Cross-matching ID:
  DrugBank ID: DB04969
  TTD ID: D0B6EA

References

• [1] ClinicalTrials.gov (NCT00149396) Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus NV1020 to Treat Colorectal Cancer Metastatic to Liver. U.S. National Institutes of Health.